Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 21, 2021 - Issue 2
Submit an article Journal homepage
1,841
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Fortifying the diagnostic-frontiers with nanoscale technology amidst the COVID-19 catastrophe

Rocktotpal Konwarha Division of Nanobiomaterials and Nanomedicine, Uniglobe Scientific Pvt. Ltd., 7/9, Kishan Garh, Vasant Kunj, New Delhi, IndiaORCID Iconhttps://orcid.org/0000-0003-4767-4531View further author information
ORCID Icon &
William C. Chob Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, SAR, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4174-4586View further author information
ORCID Icon
Pages 131-135 | Received 04 Jan 2021, Accepted 18 Jan 2021, Published online: 01 Mar 2021

References

  • Clemente-Suárez VJ, Dalamitros AA, Beltran-Velasco AI, et al. Social and psychophysiological consequences of the COVID-19 pandemic: an extensive literature review. Front Psychol. 2020;11:3077.
  • Maugeri G, Castrogiovanni P, Battaglia G, et al. The impact of physical activity on psychological health during Covid-19 pandemic in Italy. Heliyon. 2020;6(6):e04315.
  • Le TT, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305–306.
  • Konwarh R. Nanobodies: prospects of expanding the gamut of neutralizing antibodies against the novel coronavirus, SARS-CoV-2. Front Immunol. 2020;11:1531.
  • Islam KU, Iqbal J. An update on molecular diagnostics for COVID-19. Front Cell Infect Microbiol. 2020;10:560616.
  • Wang H, Li X, Li T, et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020;39(9):1629–1635.
  • Cyranoski D. Profile of a killer: the complex biology powering the coronavirus pandemic. Nature. 2020;581(7806):22–26.
  • Zhang L, Guo H Biomarkers of COVID-19 and technologies to combat SARS-CoV-2. Advances in Biomarker Sciences and Technology (ABST) 2020; 2: 1–23.
  • Wang M, Fu A, Hu B, et al. Nanopore targeted sequencing for the accurate and comprehensive detection of SARS‐CoV‐2 and other respiratory viruses. Small. 2020;16(32):2002169.
  • Konwarh R. Can CRISPR/Cas technology be a felicitous stratagem against the COVID-19 fiasco? prospects and hitches. Front Mol Biosci. 2020;7:557377.
  • Talebian S, Wallace GG, Schroeder A, et al. Nanotechnology-based disinfectants and sensors for SARS-CoV-2. Nat Nanotechnol. 2020;15(8):618–621.
  • Jiao J, Duan C, Xue L, et al. DNA nanoscaffold-based SARS-CoV-2 detection for COVID-19 diagnosis. Biosens Bioelectron. 2020;167:112479.
  • Zhao Z, Cui H, Song W, et al. A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2. Preprint at bioRxiv 2020 10.1101/2020.02.22.961268.
  • Lamote K, Janssens E, Schillebeeckx E, et al. The scent of COVID-19: viral (semi-)volatiles as fast diagnostic biomarkers? J Breath Res. 2020;14(4):042001.
  • Shan B, Broza YY, Li W, et al. Multiplexed nanomaterial-based sensor array for detection of COVID-19 in exhaled breath. ACS Nano. 2020;14(9):12125–12132.
  • Alafeef M, Dighe K, Moitra P, et al. Rapid, ultrasensitive, and quantitative detection of SARS-CoV-2 using antisense oligonucleotides directed electrochemical biosensor chip. ACS Nano. 2020;14(12):17028–17045.
  • Moitra P, Alafeef M, Dighe K, et al. Selective naked-eye detection of SARS-CoV-2 mediated by N gene targeted antisense oligonucleotide capped plasmonic nanoparticles. ACS Nano. 2020;14(6):7617–7627.
  • Qiu G, Gai Z, Tao Y, et al. Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection. ACS Nano. 2020;14(5):5268–5277.
  • Seo G, Lee G, Kim MJ, et al. Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS Nano. 2020;14(4):5135–5142.
  • Chen Z, Zhang Z, Zhai X, et al. Rapid and sensitive detection of anti-SARS-CoV-2 IgG, using lanthanide-doped nanoparticles-based lateral flow immunoassay. Anal Chem. 2020;92(10):7226–7231.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.